A previous study showed that CPXM1 is closely associated with leukemia stem cells and can be used as a prognostic gene in patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) (Wang et al., 2020). Here, CPXM1 is linked to acute myeloid leukemia.